VIVES Partners — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

ATB Therapeuticsatbtherapeutics.com in 𝕏Nov 2024✓ verified

ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.

BiotechHealthtechMedical Devices

Dr. Mark Throsby(Chief Executive Officer)

Co-investorsMRL Ventures Fund V-Bio Ventures EQT Life Sciences Sambrinvest Wallonie Entreprendre EQT

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.